Guidance for industry : pharmaceutical components at risk for melamine contamination.
| Other author | Center for Drug Evaluation and Research (U.S.) |
| Other author | Center for Veterinary Medicine (U.S.) |
| Format | Electronic |
| Publication Info | Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Veterinary Medicine, [2009] |
| Description | 1 online resource (5 p.) |
| Supplemental Content | https://purl.fdlp.gov/GPO/LPS116538 |
| Subjects |
| Portion of title | Pharmaceutical components at risk for melamine contamination |
| General note | "Current Good Manufacturing Practice (CGMP)." |
| General note | "August 2009." |
| General note | GPO Cataloging Record Distribution Program (CRDP). |
| Issued in other form | Print version: Guidance for industry |
| GPO item number | 0499-T (online) |
| Govt. docs number | HE 20.4702:P 49/8 |